- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02119377
First Australian National Trans Mental Health Study
A Mixed-Methods Study of Mental Health and Associated Factors in Transgender and Transsexual (Trans) People
This is an Internet-based survey of transgender and transsexual (trans) people aged 18 years and older living in Australia. This population has received limited attention from public health researchers, planners, and practitioners. However, a growing body of evidence suggests that trans people experience disparities in several important areas of health compared with the population generally. In particular, trans people are more likely to experience mental health problems (notably depression and anxiety disorders), use alcohol, tobacco, and illicit drugs, and think about or attempt suicide. Additionally, trans people commonly report that their physical and mental health needs are not met, and underutilise preventive health care.
Participants were recruited using several non-probability sampling techniques, (including purposive sampling and snowball sampling), because random sampling is not possible with this population. Medical, social, support, and advocacy networks used by trans people were used to promote the study. A mixed quantitative and qualitative methodology was used. Validated quantitative instruments were used to obtain measures of health and well-being, which will be compared against population norms. Qualitative items complement these measures, providing rich experiential data.
The investigators hypothesised that:
- the prevalence of depressive and anxiety disorders will be higher than for the population generally, and that these conditions will commonly be undiagnosed and untreated;
- depressive and anxiety disorders will be associated with risky behaviours, such as tobacco, alcohol, and illicit drug use; and,
- trans people will report poor relationships with medical practitioners.
The investigators hypothesised that poor mental health is a consequence of several interrelated factors: body dysphoria (as a consequence of experiencing difficulty accessing medical treatment to alter sexual characteristics); societal discrimination and stigma (including harassment and violence); institutionalised discrimination (including difficulty changing identifying documents, and exclusion of surgical procedures and related treatments from public and private health systems); social isolation; and the belief held by many clinicians that transsexualism is a mental disorder (which may be a barrier to trans people forming trusting relationships with medical practitioners).
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Western Australia
-
Perth, Western Australia, Australia, 6102
- Curtin University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Live in Australia
- Self-identify as trans
Exclusion Criteria:
- Aged less than 18 years
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Transgender and Transsexual People
Transgender and transsexual (trans) people aged 18 years or older living in Australia were invited to complete a questionnaire assessing a range of mental and physical health domains.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of depressive and anxiety disorders
Time Frame: At time of entry into study (cross-sectional)
|
Assessed by self-report, and with the Patient Health Questionnaire (PHQ)
|
At time of entry into study (cross-sectional)
|
Perceived physical and mental health status
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with the 36-item Short Form Health Survey (SF-36)
|
At time of entry into study (cross-sectional)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Use of alcohol, tobacco, and illicit drugs
Time Frame: At time of entry into study (cross-sectional)
|
Assessed by self-report
|
At time of entry into study (cross-sectional)
|
Patient-doctor relationship between trans people and their general practitioners, and doctors generally
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with the Patient-Doctor Relationship Questionnaire (PDRQ-9) and other quantitative and qualitative questions
|
At time of entry into study (cross-sectional)
|
Body image
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with the Body Image Quality of Life Inventory (BIQLI)
|
At time of entry into study (cross-sectional)
|
Factors that encourage and discourage trans people from accessing health care
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with qualitative questions
|
At time of entry into study (cross-sectional)
|
Factors that protect and promote mental health in trans people
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with qualitative questions
|
At time of entry into study (cross-sectional)
|
Use of hormone therapy and desire for, and uptake of transition-related surgery
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with quantitative and qualitative questions
|
At time of entry into study (cross-sectional)
|
Experiences of discrimination and harassment
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with quantitative and qualitative questions
|
At time of entry into study (cross-sectional)
|
Desire to, and success changing identifying documentation
Time Frame: At time of entry into study (cross-sectional)
|
Assessed with quantitative and qualitative questions
|
At time of entry into study (cross-sectional)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Zoë Hyde, MPH PhD, Curtin University
- Principal Investigator: Maryanne Doherty, MSc PhD, Curtin University
- Principal Investigator: Peter Tilley, MPsych, Curtin University
- Principal Investigator: Kieran A. McCaul, MPH PhD, The University of Western Australia
- Principal Investigator: Rosanna Rooney, MPsych PhD, Curtin University
- Principal Investigator: Jonine Jancey, PhD, Curtin University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CB:gc:6722
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transsexualism
-
Medical University of ViennaCompleted
-
University Hospital, GhentOrganonCompleted
-
Max-Planck-Institute of PsychiatryUniversity of Erlangen-Nürnberg Medical School; Institute for Sex Research... and other collaboratorsCompletedTranssexualismGermany
-
Medical University of ViennaCompleted
-
Karolinska InstitutetRegion StockholmCompleted
-
Unita Complessa di Ostetricia e GinecologiaSchering-PloughCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloRecruitingHematologic Diseases | Transsexualism | TestosteroneBrazil
-
Medical University of GrazRecruitingGender Dysphoria | Body Image | Sexuality | Transsexualism | Gender Identity DisorderAustria
-
Universitätsklinikum Hamburg-EppendorfCompletedGender Dysphoria | Gender Identity | Transsexualism | Gender Identity Disorder | Gender IncongruenceGermany
-
Universitätsklinikum Hamburg-EppendorfUnknownGender Dysphoria | Gender Identity | Transsexualism | Gender Identity DisorderGermany
Clinical Trials on questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Minneapolis Veterans Affairs Medical CenterUnited States Department of DefenseCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury)United States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Rabin Medical CenterCompleted
-
University of PalermoRecruitingFamilial Mediterranean Fever | Non-celiac Gluten SensitivityItaly